Summaires for patients. Factors associated with the development of antibiotic-resistant bacteria.

Abstract

Summaries for Patients7 August 2001Factors Associated with the Development of Antibiotic-Resistant BacteriaSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-3-200108070-00005 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Unnecessary use of antibiotics is thought to be an important cause of bacterial resistance to antibiotics. One type of bacteria known as vancomycin-resistant enterococci (VRE), which is usually found in the bowel, can cause serious or fatal infections and is extremely difficult to treat. Limited information is available on exactly where VRE occur in hospitals and what factors are associated with their presence.Why did the researchers do this particular study?To evaluate how patterns of antibiotic use affected the frequency of finding VRE in hospital intensive care ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units.” It is in the 7 August 2001 issue of Annals of Internal Medicine (volume 135, pages 175-183). The authors are SK Fridkin, JR Edwards, JM Courval, H Hill, FC Tenover, R Lawton, RP Gaynes, and JE McGowan Jr., for the Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units Scott K. Fridkin , Jonathan R. Edwards , Jeanne M. Courval , Holly Hill , Fred C. Tenover , Rachel Lawton , Robert P. Gaynes , John E. McGowan Jr. , and Metrics 7 August 2001Volume 135, Issue 3Page: I-27KeywordsAntibioticsBacteriaInpatientsIntensive care unitsNosocomial infectionsNumber needed to inviteOutpatient clinicsSurgeryVancomycinVancomycin resistant enterococcus ePublished: 7 August 2001 Issue Published: 7 August 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...